(Hu et al., 2014) Cas9 nuclease have been used successfully to target the E6 or E7 oncogenes in HPV-induced cancer cell lines to cleave the HPV genome leading to the elevation of p53 or pRb expression and induction of cancer cell death. Here, TP53 is linked to cancer.